2023 Q3 Form 10-Q Financial Statement

#000102373123000129 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $185.0M $183.3M $187.6M
YoY Change -1.28% -2.31% 26.49%
Cost Of Revenue $57.10M $54.67M $66.67M
YoY Change -7.17% -18.0% 11.58%
Gross Profit $127.9M $128.6M $120.9M
YoY Change 1.61% 6.34% 36.55%
Gross Profit Margin 69.14% 70.17% 64.46%
Selling, General & Admin $96.27M $94.73M $112.7M
YoY Change -10.73% -15.98% 10.53%
% of Gross Profit 75.27% 73.66% 93.22%
Research & Development $34.21M $35.29M $34.96M
YoY Change -4.75% 0.96% 37.66%
% of Gross Profit 26.75% 27.44% 28.9%
Depreciation & Amortization $11.84M $2.126M $2.789M
YoY Change -13.02% -23.77% -4.55%
% of Gross Profit 9.26% 1.65% 2.31%
Operating Expenses $187.6M $184.7M $214.4M
YoY Change 27.73% -13.84% 14.54%
Operating Profit -$2.583M -$1.410M -$26.75M
YoY Change -87.69% -94.73% -31.09%
Interest Expense -$8.929M -$8.970M -$1.456M
YoY Change 47.54% 516.07% -69.95%
% of Operating Profit
Other Income/Expense, Net -$5.258M -$12.47M $1.116M
YoY Change -137.69% -1217.65% -123.14%
Pretax Income -$7.841M -$13.88M -$25.64M
YoY Change -28.98% -45.85% -41.26%
Income Tax -$389.0K $1.444M $405.0K
% Of Pretax Income
Net Earnings -$7.452M -$15.33M -$26.04M
YoY Change -35.97% -41.15% -40.68%
Net Earnings / Revenue -4.03% -8.36% -13.88%
Basic Earnings Per Share -$0.06 -$0.13 -$0.22
Diluted Earnings Per Share -$0.06 -$0.13 -$0.22
COMMON SHARES
Basic Shares Outstanding 119.9M shares 116.4M shares 119.7M shares
Diluted Shares Outstanding 120.8M shares 116.8M shares 119.7M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $148.8M $138.2M $141.6M
YoY Change 13.63% -2.44% 0.79%
Cash & Equivalents $144.0M $122.2M $92.69M
Short-Term Investments $4.744M $15.95M $48.95M
Other Short-Term Assets $33.97M $32.93M $38.55M
YoY Change -54.34% -14.57% 6.87%
Inventory
Prepaid Expenses
Receivables $61.06M $64.95M $55.44M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $281.9M $274.5M $272.7M
YoY Change 6.93% 0.64% 2.44%
LONG-TERM ASSETS
Property, Plant & Equipment $53.51M $54.54M $73.88M
YoY Change -56.47% -26.18% -18.62%
Goodwill $265.7M $266.4M $265.0M
YoY Change 1.27% 0.51% 101.39%
Intangibles $96.91M $102.0M $122.7M
YoY Change -17.51% -16.88% 674.61%
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $14.34M $15.10M $18.03M
YoY Change -83.98% -16.22% -10.92%
Total Long-Term Assets $541.8M $554.0M $616.4M
YoY Change -8.52% -10.13% 50.56%
TOTAL ASSETS
Total Short-Term Assets $281.9M $274.5M $272.7M
Total Long-Term Assets $541.8M $554.0M $616.4M
Total Assets $823.7M $828.5M $889.1M
YoY Change -3.76% -6.82% 31.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $49.39M $42.54M $42.58M
YoY Change 12.65% -0.11% 28.14%
Accrued Expenses $47.47M $56.23M $66.90M
YoY Change -24.29% -15.96% 22.39%
Deferred Revenue $33.22M $40.41M $34.06M
YoY Change 7.66% 18.63% 54.94%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $63.15M $63.04M
YoY Change
Total Short-Term Liabilities $229.1M $236.3M $175.4M
YoY Change 35.57% 34.72% 44.73%
LONG-TERM LIABILITIES
Long-Term Debt $407.6M $406.6M $494.4M
YoY Change -21.12% -17.77% 58.06%
Other Long-Term Liabilities $4.460M $7.227M $2.936M
YoY Change -94.78% 146.15% -45.92%
Total Long-Term Liabilities $4.460M $7.227M $497.4M
YoY Change -99.26% -98.55% 56.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $229.1M $236.3M $175.4M
Total Long-Term Liabilities $4.460M $7.227M $497.4M
Total Liabilities $713.3M $723.6M $755.6M
YoY Change -7.5% -4.24% 45.63%
SHAREHOLDERS EQUITY
Retained Earnings -$815.7M -$808.2M -$745.8M
YoY Change 7.69% 8.37% 17.46%
Common Stock $122.0K $119.0K $120.0K
YoY Change 9.91% -0.83% 8.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $110.4M $104.9M $133.5M
YoY Change
Total Liabilities & Shareholders Equity $823.7M $828.5M $889.1M
YoY Change -3.76% -6.82% 31.6%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$7.452M -$15.33M -$26.04M
YoY Change -35.97% -41.15% -40.68%
Depreciation, Depletion And Amortization $11.84M $2.126M $2.789M
YoY Change -13.02% -23.77% -4.55%
Cash From Operating Activities $17.47M $26.47M $5.841M
YoY Change 26.22% 353.23% 44.87%
INVESTING ACTIVITIES
Capital Expenditures $5.330M $186.0K $971.0K
YoY Change -284.24% -80.84% 10.59%
Acquisitions $0.00 $1.250M
YoY Change -100.0%
Other Investing Activities $11.27M $10.47M -$2.561M
YoY Change -39.34% -508.67% -31.19%
Cash From Investing Activities $5.950M $6.792M -$5.841M
YoY Change -62.07% -216.28% -47.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $25.00M $0.00
YoY Change
Cash From Financing Activities 2.360M -$25.00M $65.00K
YoY Change -114.52% -38561.54% -98.11%
NET CHANGE
Cash From Operating Activities 17.47M $26.47M $5.841M
Cash From Investing Activities 5.950M $6.792M -$5.841M
Cash From Financing Activities 2.360M -$25.00M $65.00K
Net Change In Cash 25.78M $10.48M -$6.620M
YoY Change 94.29% -258.35% 104.13%
FREE CASH FLOW
Cash From Operating Activities $17.47M $26.47M $5.841M
Capital Expenditures $5.330M $186.0K $971.0K
Free Cash Flow $12.14M $26.29M $4.870M
YoY Change -27.45% 439.77% 54.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114659255 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114659255 shares
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35292000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34955000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
68505000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
83527000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26226000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29219000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
184697000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
214374000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1410000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-26754000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12473000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1116000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13883000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25638000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1444000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
405000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15327000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-26043000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116777000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116777000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119721000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119721000 shares
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8970000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-625000 usd
CY2023Q2 eght Amortization Of Convertible Debt Issuance Costs And Discounts
AmortizationOfConvertibleDebtIssuanceCostsAndDiscounts
1108000 usd
CY2022Q2 eght Amortization Of Convertible Debt Issuance Costs And Discounts
AmortizationOfConvertibleDebtIssuanceCostsAndDiscounts
831000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
250000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1766000 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-804000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2475000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
425000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
97000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15327000 usd
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
290000 usd
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-94000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1441000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8384000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13596000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34521000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
182366000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
65000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31807000 usd
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-94000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-8419000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
133522000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
99906000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18559000 usd
CY2023Q2 eght Apic Share Based Payment Arrangement Acquisition Increase For Cost Recognition
APICShareBasedPaymentArrangementAcquisitionIncreaseForCostRecognition
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1441000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
104869000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15327000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-26043000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
2126000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
2789000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5099000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5476000 usd
CY2023Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
5282000 usd
CY2022Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
5964000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1109000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
831000 usd
CY2023Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
10019000 usd
CY2022Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
9166000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
490000 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
695000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2507000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3121000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
18195000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
27814000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1766000 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
250000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-184000 usd
CY2022Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
456000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3397000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
99000 usd
CY2023Q2 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
7209000 usd
CY2022Q2 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
9246000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2327000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
692000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2084000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-13786000 usd
CY2023Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5504000 usd
CY2022Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-605000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26473000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5841000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
186000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
971000 usd
CY2023Q2 us-gaap Payments For Software
PaymentsForSoftware
3488000 usd
CY2022Q2 us-gaap Payments For Software
PaymentsForSoftware
2309000 usd
CY2023Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3093000 usd
CY2022Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18838000 usd
CY2023Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
CY2022Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1937000 usd
CY2023Q2 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
13559000 usd
CY2022Q2 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
15590000 usd
CY2023Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1250000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6792000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5841000 usd
CY2023Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
CY2022Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
65000 usd
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
25000000 usd
CY2022Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25000000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
65000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2218000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6685000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10483000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6620000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112729000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100714000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123212000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94094000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
37000 usd
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122229000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92686000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
165000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
590000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
818000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
818000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123212000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94094000 usd
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">USE OF ESTIMATES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and equity, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to current expected credit losses, returns reserve for expected cancellations, fair value of and/or potential impairment of goodwill and intangible assets, capitalized internal-use software costs, benefit period for deferred commissions, stock-based compensation, incremental borrowing rate used to calculate operating lease liabilities, income and sales tax liabilities, convertible senior notes fair value, litigation, and other contingencies. The Company bases its estimates on known facts and circumstances, historical experience, and various other assumptions. Actual results could differ from those estimates under different assumptions or conditions.</span></div>
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
64951000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62307000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
11989000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
11581000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
10301000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
11141000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40410000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
34909000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10618000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10615000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16900000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
790000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.85
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.15
CY2023Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
10000000 usd
CY2022Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
9200000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2022Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023Q2 eght Cash Cash Equivalentsand Debt Securities Availableforsale Amortized Cost
CashCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost
139164000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6000 usd
CY2023Q2 eght Cash Cash Equivalentsand Debt Securities Availableforsale
CashCashEquivalentsandDebtSecuritiesAvailableforsale
139158000 usd
CY2023Q1 eght Cash Cash Equivalentsand Debt Securities Availableforsale Amortized Cost
CashCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost
138926000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
59000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
28000 usd
CY2023Q1 eght Cash Cash Equivalentsand Debt Securities Availableforsale
CashCashEquivalentsandDebtSecuritiesAvailableforsale
138957000 usd
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5748000 usd
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5497000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
152860000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
50847000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
102013000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
152881000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
45769000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
107112000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
15297000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
19095000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
13896000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
11757000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
11044000 usd
CY2023Q2 eght Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
30924000 usd
CY2023Q2 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Indemnifications</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the normal course of business, the Company may agree to indemnify other parties, including customers, lessors, and parties to other transactions with the Company with respect to certain matters, such as breaches of representations or covenants or intellectual property infringement or other claims made by third parties. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. In addition, the Company has entered into indemnification agreements with its officers and directors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">It is not possible to determine the maximum potential amount of the Company's exposure under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. Historically, payments made by the Company under these agreements have not had a material impact on the Company's operating results, financial position, or cash flows. Under some of these agreements, however, the Company's potential indemnification liability may not have a contractual limit.</span></div>
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
28100000 usd
CY2023Q2 eght Purchase Obligation Service Contract Period
PurchaseObligationServiceContractPeriod
P3Y
CY2023Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
5700000 usd
CY2023Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
10000000 usd
CY2023Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
10500000 usd
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5700000 usd
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5500000 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
18195000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
27814000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.104
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.016
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15327000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15327000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-26043000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26043000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116777000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116777000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119721000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119721000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18929000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18632000 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
183287000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187620000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54538000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57871000 usd
CY2023 eght Related Party Contract Term
RelatedPartyContractTerm
P2Y
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1400000 usd
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001023731-23-000129-index-headers.html Edgar Link pending
0001023731-23-000129-index.html Edgar Link pending
0001023731-23-000129.txt Edgar Link pending
0001023731-23-000129-xbrl.zip Edgar Link pending
a8x8063023ex311.htm Edgar Link pending
a8x8063023ex312.htm Edgar Link pending
a8x8063023ex321.htm Edgar Link pending
a8x8063023ex322.htm Edgar Link pending
eght-20230630.htm Edgar Link pending
eght-20230630.xsd Edgar Link pending
eght-20230630_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
eght-20230630_cal.xml Edgar Link unprocessable
eght-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
eght-20230630_pre.xml Edgar Link unprocessable
eght-20230630_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
eght-20230630_def.xml Edgar Link unprocessable